SCHEMBL3887165

SCHEMBL3887165

N#CC1(N2CCOCC2)CN(C(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ KCNA5 P22460 1/20 0.41
▸ OPRD1 P41143 3/20 0.40
▸ CYP2D6 P10635 4/20 0.40
▸ CYP3A4 P08684 4/20 0.40
▸ USP2 O75604 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ OPRM1 P35372 3/20 0.39
▸ OPRK1 P41145 2/20 0.39
▸ OPRL1 P41146 2/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.38
▸ GPR55 Q9Y2T6 1/20 0.38
▸ GRM5 P41594 1/20 0.38
▸ CHRM2 P08172 1/20 0.38
▸ CHRM4 P08173 1/20 0.38
▸ CHRM5 P08912 1/20 0.38
▸ ADRA2A P08913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1189507 0.78 ALDH1A1 (0.49) ALDH1A1KCNA5OPRD1CYP2D6CYP3A4
SCHEMBL5532770 0.74 ALDH1A1 (0.46) ALDH1A1KCNA5OPRD1CYP2D6CYP3A4
SCHEMBL2793637 0.74 ALDH1A1 (0.67) ALDH1A1KCNA5OPRD1CYP2D6CYP3A4
SCHEMBL9230667 0.73 CYP2D6 (0.47) ALDH1A1OPRD1CYP2D6CYP3A4USP2
SCHEMBL5502867 0.71 OPRM1 (0.45) ALDH1A1KCNA5OPRD1CYP2D6CYP3A4
SCHEMBL5455644 0.70 NPSR1 (0.53) OPRD1CYP2D6CYP3A4USP2CYP2C9
SCHEMBL5527398 0.70 OPRL1 (0.49) OPRD1CYP2D6CYP3A4USP2CYP2C9
SCHEMBL13449264 0.70 CYP3A4 (0.47) ALDH1A1OPRD1CYP2D6CYP3A4USP2
SCHEMBL7440573 0.69 ALDH1A1 (0.56) ALDH1A1KCNA5OPRD1CYP2D6CYP3A4
SCHEMBL4840431 0.68 NPSR1 (0.46) OPRD1CYP2D6CYP3A4USP2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572792-B2 Azetidine glycine transporter inhibitors MERCK & CO., INC. (US) 2009-08-11 — — US disclosed
US-7572792-B2 Azetidine glycine transporter inhibitors MERCK & CO., INC. (US) 2009-08-11 — — US disclosed
US-7572792-B2 Azetidine glycine transporter inhibitors MERCK & CO., INC. (US) 2009-08-11 — — US disclosed
US-20080021010-A1 Azetidine Glycine Transporter Inhibitors MERCK SHARP & DOHME LIMITED (GB) 2008-01-24 — — US disclosed
US-20080021010-A1 Azetidine Glycine Transporter Inhibitors MERCK SHARP & DOHME LIMITED (GB) 2008-01-24 — — US disclosed
US-20080021010-A1 Azetidine Glycine Transporter Inhibitors MERCK SHARP & DOHME LIMITED (GB) 2008-01-24 — — US disclosed
EP-1745018-A1 AZETIDINE GLYCINE TRANSPORTER INHIBITORS Merck & Co., Inc. (US) 2007-01-24 — — EP disclosed
WO-2005110983-A1 AZETIDINE GLYCINE TRANSPORTER INHIBITORS MERCK & CO., INC. (US) 2005-11-24 — — WO disclosed
WO-2005110983-A1 AZETIDINE GLYCINE TRANSPORTER INHIBITORS MERCK & CO., INC. (US) 2005-11-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021010-A1 Azetidine Glycine Transporter Inhibitors SLC1A2, SLC18A2, SLC1A1 ALDH1A1 1719/4885KCNA5 1632/4885OPRD1 452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback